Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma (clinicaltrials.gov) - Oct 3, 2026 - P2 | N=59 | Recruiting | Sponsor: Vanderbilt-Ingram Cancer Center | Not yet recruiting ➔ Recruiting | Trial completion date: Oct 2030 ➔ Oct 2029 | Trial primary completion date: Oct 2029 ➔ Mar 2028
Enrollment open • Trial completion date • Trial primary completion date • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Follicular Lymphoma • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Marginal Zone Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Primary Mediastinal Large B-Cell Lymphoma • BCL2 • BCL6 • CD4
|